Prime Health Isabgol 500mg Capsules
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Plantago ovata Source : Enveloppe | 500 mg | Not calculated |
| Plantago ovata Source : Enveloppe | 0.5 g | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 13 years | minimum: 4 Capsule ; maximum: 5 Capsule | 3 days |
Uses authorised in Canada
(Used in Herbal Medicine to) promote(s) bowel movements by increasing bulk volume and water content. (Used in Herbal Medicine to) provide(s) gentle relief of constipation and/or irregularity. (Used in Herbal Medicine as a) bulk-forming laxative.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you have difficulty swallowing. Do not use if you have diabetes mellitus in which blood sugar is difficult to regulate. Do not use if you are experiencing a sudden change in bowel habits that has persisted for more than 2 weeks, undiagnosed rectal bleeding, or failure to defaecate following the use of another laxative product.
- Effets indésirables connus
May cause temporary gas and/or bloating. Hypersensitivity, such as allergy, has been known to occur following inhaled and/or ingested psyllium; in which case, discontinue use.
Product record
- Other names
- Maple Health Psyllium 500mg Vegan Capsules, Maple Leaf Psyllium 500mg Vegan Capsules, Prime Health Natural laxative 500mg Vegan Capsules, Prime Health Psyllium 500mg vegan Capsules, Prime Psyllium 500mg Vegan Capsules
- Licence holder
- Prime Health Ltd. (Canada Global Life Sciences)
- NPN or DIN-HM
- 80041746
- Status
- Active licence
- Licence date
- 17 April 2013
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80041746
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Prime Health Isabgol 500mg Capsules (Prime Health Ltd. (Canada Global Life Sciences)): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80041746-prime-health-isabgol-500mg-capsules, updated 17 April 2013.